Towards Evidence-Based Management of Inherited Breast and Breast-Ovarian Cancer

por Møller, Pål
Publicado 2004

The Prospective Lynch Syndrome Database reports enable evidence-based personal precision health care

por Møller, Pål
Publicado 2020

The Prospective Lynch Syndrome Database: background, design, main results and complete MySQL code

por Møller, Pål
Publicado 2022

The BRCA2 variant c.68-7 T>A is associated with breast cancer

por Møller, Pål, Hovig, Eivind
Publicado 2017

Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer

por Møller, Pål, Hovig, Eivind
Publicado 2018

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway

por Møller, Pål, Hovig, Eivind
Publicado 2017

Inherited Cancer Genetic Epidemiology to Improve Precision Medicine

por Møller, Pål, Evans, Dafydd Gareth
Publicado 2022

Costs and Benefits of Diagnosing Familial Breast Cancer

por Heimdal, Ketil, Mæhle, Lovise, Møller, Pål
Publicado 1999

MRI screening of women with hereditary predisposition to breast cancer: diagnostic performance and survival analysis

por Tharmaratnam, Kukatharmini, Hagen, Anne Irene, Møller, Pål
Publicado 2014

No Sib Pair Concordance for Breast or Ovarian Cancer in BRCA1 Mutation Carriers

por Møller, Pål, Mæhle, Lovise, Clark, Neal, Apold, Jaran
Publicado 2007

Uptake of Genetic Testing and Pre-Test Levels of Mental Distress in Norwegian Families with Known BRCA1 Mutations

por Reichelt, Jon G., Dahl, Alv A., Heimdal, Ketil, Møller, Pål
Publicado 1999

Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift

por Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Publicado 2019

Correction: Møller, P.; et al. Causes for Frequent Pathogenic BRCA1 Variants Include Low Penetrance in Fertile Ages, Recurrent De-Novo Mutations and Genetic Drift. Cancers 2019, 11...

por Møller, Pål, Dominguez-Valentin, Mev, Rødland, Einar Andreas, Hovig, Eivind
Publicado 2020

Prospective observational data informs understanding and future management of Lynch syndrome: insights from the Prospective Lynch Syndrome Database (PLSD)

por Seppälä, Toni T., Dominguez-Valentin, Mev, Sampson, Julian R., Møller, Pål
Publicado 2020

MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer

por Stormorken, Astrid, Heintz, Karen-Marie, Andresen, Per Arne, Hovig, Eivind, Møller, Pål
Publicado 2006

BRCA1 1675delA and 1135insA Account for One Third of Norwegian Familial Breast-Ovarian Cancer and Are Associated with Later Disease Onset than Less Frequent Mutations

por Borg, Åke, Dørum, Anne, Heimdal, Ketil, Mæhle, Lovise, Hovig, Eivind, Møller, Pål
Publicado 1999

Survival in Norwegian BRCA1 mutation carriers with breast cancer

por Hagen, Anne Irene, Tretli, Steinar, Mæhle, Lovise, Apold, Jaran, Vedå, Nina, Møller, Pål
Publicado 2009

Ten modifiers of BRCA1 penetrance validated in a Norwegian series

por Heramb, Cecilie, Ekstrøm, Per Olaf, Tharmaratnam, Kukatharmini, Hovig, Eivind, Møller, Pål, Mæhle, Lovise
Publicado 2015

Germline PTEN mutations are rare and highly penetrant

por Rustad, Cecilie F, Bjørnslett, Merete, Heimdal, Ketil R, Mæhle, Lovise, Apold, Jaran, Møller, Pål
Publicado 2006

The clinical utility of genetic testing in breast cancer kindreds: a prospective study in families without a demonstrable BRCA mutation

por Møller, Pål, Stormorken, Astrid, Holmen, Marit Muri, Hagen, Anne Irene, Vabø, Anita, Mæhle, Lovise
Publicado 2014